tiprankstipranks
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
US Market

Larimar Therapeutics (LRMR) Income Statement

Compare
616 Followers

Larimar Therapeutics Income Statement

Last quarter (Q4 2024), Larimar Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Larimar Therapeutics's net income was $-28.82M. See Larimar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -311.00K$ -272.00K$ -326.00K$ -155.00K
Operating Expenses
$ 90.89M$ 41.76M$ 36.53M$ 50.47M$ 42.80M
Depreciation and Amortization
$ 0.00$ 311.00K$ 272.00K$ 326.00K$ 155.00K
EBITDA
$ -90.89M$ -41.45M$ -35.08M$ -50.14M$ -42.65M
Operating Income
$ -90.89M$ -41.76M$ -36.53M$ -50.47M$ -42.80M
Other Income/Expenses
$ 10.29M$ 4.81M$ 1.17M$ -171.00K$ 322.00K
Pretax Income
$ -80.60M$ -36.95M$ -35.35M$ -50.64M$ -42.48M
Net Income
$ -80.60M$ -36.95M$ -34.18M$ -50.31M$ -42.33M
Per Share Metrics
Basic EPS
$ -1.32$ -0.84$ -1.33$ -2.93$ -3.56
Diluted EPS
$ -1.32$ -0.84$ -1.33$ -2.93$ -3.56
Weighted Average Shares Outstanding
61.26M 43.90M 25.76M 17.16M 11.88M
Weighted Average Shares Outstanding (Diluted)
61.26M 43.90M 25.76M 17.16M 11.88M
Currency in USD

Larimar Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis